A. Adrovic Et Al. , "TOCILIZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS," Annual European Congress of Rheumatology (EULAR) , vol.78, Madrid, Spain, pp.1929, 2019
Adrovic, A. Et Al. 2019. TOCILIZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS. Annual European Congress of Rheumatology (EULAR) , (Madrid, Spain), 1929.
Adrovic, A., Sahin, S., Yildiz, M., Koker, O., Barut, K., & KASAPÇOPUR, Ö., (2019). TOCILIZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS . Annual European Congress of Rheumatology (EULAR) (pp.1929). Madrid, Spain
Adrovic, Amra Et Al. "TOCILIZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS," Annual European Congress of Rheumatology (EULAR), Madrid, Spain, 2019
Adrovic, Amra Et Al. "TOCILIZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS." Annual European Congress of Rheumatology (EULAR) , Madrid, Spain, pp.1929, 2019
Adrovic, A. Et Al. (2019) . "TOCILIZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS." Annual European Congress of Rheumatology (EULAR) , Madrid, Spain, p.1929.
@conferencepaper{conferencepaper, author={Amra Adrovic Et Al. }, title={TOCILIZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH JUVENILE SYSTEMIC SCLEROSIS}, congress name={Annual European Congress of Rheumatology (EULAR)}, city={Madrid}, country={Spain}, year={2019}, pages={1929} }